Accreditation
Academy of Next Wave Investigators™ in CLL and NHL
Target Audience
Educational Objectives
Upon completion of this activity, participants should be able to:
- Evaluate techniques to develop the skills of young investigators in CLL and NHL, including presentation, leadership, and career development skills
- Facilitate the presentation of clinical data from young investigators and allow feedback from dedicated mentors on how best to focus data presentation
Foster mentor-mentee relationships among senior and junior physicians caring for patients with CLL and NHL
Assess strategies for young investigators to participate in clinical trials, including the importance of clinical trial design, trial endpoints, and protocol adherence
Faculty and Disclosure of Conflicts of Interest
PACE requires planners, faculty, and others who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.
Faculty
Conflicts of Interest
John P. Leonard, MD – Co-Chair
Richard T. Silver Distinguished Professor of Hematology and Medical Oncology
Senior Associate Dean for Innovation and Initiatives
Executive Vice Chairman, Department of Medicine
Weill Cornell Medicine
New York, New York
Matthew S. Davids, MD, MMSc – Co-Chair
Associate Professor of Medicine
Harvard Medical School
Director of Clinical Research, Division of Lymphoma
Dana-Farber Cancer Institute
Boston, Massachusetts
Educational Programs: Aptitude Health, AXIS Medical Education, Bio Ascend, Curio Science, Medscape Education, PeerView Institute for Medical Education, Physcians’ Education Resource, PlatformQ Health Education, Plexus Communications, Research to Practice
Researcher: AbbVie, Ascentage Pharma, AstraZeneca, Genentech, Novartis, Secura Bio, TG Therapeutics
Royalties : Up-to-Date
Jonathon Cohen, MD, MS
Associate Professor
Department of Hematology and Medical Oncology
Co-Director, Lymphoma Program
Winship Cancer Institute of Emory University
Atlanta, Georgia
Advisor, Consultant, Speaker: AbbVie, ADC Therapeutics, AstraZeneca, BeiGene, HutchMed, Janssen, Lilly/Loxo
Researcher: AstraZeneca, BioInvent, BMS/Celgene, Genentech, HutchMed, Lilly/Loxo, Novartis, Takeda
Nicole Lamanna, MD
Associate Professor of Medicine
Hematology / Oncology Division
Columbia University Herbert Irving Comprehensive Cancer Center
New York, New York
Researcher: AbbVie, AstraZeneca, BeiGene, Lilly/Loxo, MingSight, Octapharma, Oncternal, TG Therapeutics
Javier Munoz, MD, MS, MBA, FACP
Director, Lymphoma Program
Mayo Clinic
Phoenix, Arizona
Advisor, Consultant, Speaker: AbbVie/Pharmacyclics, Acrotech/Aurobindo, ADC Therapeutics, Alexion, AstraZeneca, Bayer, BeiGene, BMS, Curio, Debiopharm, Epizyme, Fosunkite, Genentech/Roche, Genmab, Gilead/Kite Pharma, Innovent, Janssen, Juno/Celgene, Karyopharm, Kyowa Kirin, Lilly/Loxo, MEI Pharma, MorphoSys/Incyte, Novartis, OncView, Pfizer, Physicians’ Education Resource, Seattle Genetics, Servier, Targeted Oncology, TG Therapeutics, Verastem, Zodiac
Researcher: Bayer, Celgene, Genentech, Gilead/Kite Pharma, Incyte, Janssen, Merck, Millennium, Pharmacyclics, Portola, Seattle Genetics
Associate Professor and Deputy Chair
Section Chief, New Drug Development
Department of Lymphoma/Myeloma
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, Texas
Consultant: AbbVie, Genmab, Regeneron
Researcher: BMS, Caribou Biosciences, Epizyme, Genentech, Gilead/Kite, IGM Biosciences, Janssen, Novartis, Takeda
Speaker: AbbVie, Genmab, Regeneron
Sameer Parikh, MBBS
Consultant and Assistant Professor of Medicine and Oncology
Division of Hematology
Mayo Clinic
Rochester, Minnesota
Research Funding to Institution: AstraZeneca, Genentech, Janssen, Merck
Jennifer Woyach, MD
Professor
Division of Hematology
The Ohio State University Comprehensive Cancer Center – James
Columbus, Ohio
Consultant: AbbVie, Arqule, AstraZeneca, BeiGene, Genentech, Janssen, Loxo, Newave, Pharmacyclics
Researcher: Karyopharm, MingSight, Pharmaceuticals MorphoSys, Schrodinger, Verastem
Speaker: AbbVie, Arqule, AstraZeneca, BeiGene, Janssen, Loxo, Newave, Pharmacyclics
Has no relevant financial relationship(s) to disclose with ineligible companies
Consultant / Advisor / Speaker: Genentech, ADC Therapeutics
Consultant / Advisor / Speaker: Kite Pharma
Consultant / Advisor / Speaker: Kite, Gilead, Roche, Genentech, AstraZeneca, Acerta, Sobi, Incyte, Morphosis, Hutchinson, MediPharma, TG Therapeutics, ADC Therapeutics; Researcher: AstraZeneca, ALX Oncology, ADC Therapeutics
Disclosure of Unlabeled Use
Disclaimer
Instructions for Credit
- Visit https://www.paceducation.com/nextwave23
- Complete the activity evaluation
- Upon completion of all evaluation questions your credit will be made available for download immediately.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact bunyasaranand@bioascend.com prior to the live event.
Fee Information
Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Bio Ascend, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.